Fifth Third Bancorp Bausch Health Companies Inc. Transaction History

Fifth Third Bancorp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$7.06 - $23.63 $2,809 - $9,404	-398 Reduced 10.91%	3,250 $27,000
Q1 2022 Apr 19, 2022	SELL	$21.6 - $27.79 $15,120 - $19,453	-700 Reduced 16.1%	3,648 $83,000
Q4 2021 Feb 01, 2022	BUY	$23.0 - $29.01 $74,750 - $94,282	3,250 Added 295.99%	4,348 $120,000
Q2 2021 Aug 06, 2021	SELL	$27.43 - $32.7 $32,916 - $39,240	-1,200 Reduced 52.22%	1,098 $32,000
Q1 2021 May 07, 2021	BUY	$21.37 - $34.38 $3,098 - $4,985	145 Added 6.73%	2,298 $73,000
Q2 2020 Aug 05, 2020	BUY	$13.31 - $20.51 $2,036 - $3,138	153 Added 7.65%	2,153 $39,000
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $12,467 - $21,047	-660 Reduced 24.81%	2,000 $60,000
Q2 2019 Aug 07, 2019	SELL	$20.52 - $26.45 $2,975 - $3,835	-145 Reduced 5.17%	2,660 $67,000
Q1 2019 May 14, 2019	BUY	$20.23 - $26.29 $56,745 - $73,743	2,805 New	2,805 $69,000

254

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.63B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.